Radiofrequency-Triggered Pacemakers: Uses and Limitations

A Long-Term Study

  1. ROBERT W. PETERS, M.D.;
  2. EUGENE SHAFTON, M.D.;
  3. STUART FRANK, M.D.;
  4. ARTHUR N. THOMAS, M.D.; and
  5. MELVIN M. SCHEINMAN, M.D., F.A.C.P.
  1. San Francisco, California

    Abstract

    Seven patients with either recurrent paroxysmal supraventricular tachycardia (five), alternating bradycardiatachycardia (one), or ventricular tachycardia (one) underwent insertion of permanent radiofrequency-triggered pacemakers. Follow-up evaluation (36 ± 24 months, mean ± SD) revealed that arrhythmias were well controlled in five of seven patients, although three of the five required medication to decrease frequency of arrhythmias. Overdrive pacing was ineffective in one patient with Wolff-Parkinson-White syndrome who had recurrent bouts of atrial fibrillation or atrial flutter. One additional patient with ventricular tachycardia became refractory to overdrive atrial pacing. These studies document the long-term effectiveness of radiofrequency pacemakers in some patients with recurrent refractory arrhythmias. Careful patient selection and electrophysiologic studies are mandatory before implantation of a permanent radiofrequency pacemaker. Physicians must be aware of both the benefits and possible limitations of radiofrequency pacemakers in order to choose between pacemaker versus surgical intervention in patients with cardiac arrhythmias refractory to standard drug therapy.

    Article and Author Information

    • ▸From the Medical and Surgical Services, San Francisco General Hospital Medical Center, and the Departments of Medicine and Surgery, University of California; San Francisco, California.

    • Grant support: in part by Grant GM 16496 from the National Institutes of Health.

    • This study was done during Dr. Scheinman's tenure as an American Heart Association Teaching Scholar in Cardiology.

    • ▸Requests for reprints should be addressed to Robert W. Peters, M.D.; c/o the Editorial Office, Bldg. 40, Rm. 4101, San Francisco General Hospital Medical Center, 1001 Potrero Ave.; San Francisco, CA 94110.

      • Received May 16, 1977.
      • Accepted October 13, 1977.
    « Previous | Next Article »Table of Contents